Home/Filings/4/0000899243-18-028339
4//SEC Filing

Vukovic Vojo 4

Accession 0000899243-18-028339

CIK 0001420565other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 6:18 PM ET

Size

5.4 KB

Accession

0000899243-18-028339

Insider Transaction Report

Form 4
Period: 2018-11-05
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-11-05+150,000150,000 total
    Exercise: $2.16Exp: 2028-11-04Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted on November 5, 2018. The shares underlying the option are scheduled to vest as to 25% of the shares on November 5, 2019 and thereafter in equal monthly installments through November 5, 2022.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001466794

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 6:18 PM ET
Size
5.4 KB